Showing results (411-420 of 451) with videos related to
Sort By:
Pageof 46
PNAS Nexus|October 3, 2024
Links between climatic histories and the rise and fall of a Pacific chiefdomChuan-Chou Shen, Felicia Beardsley, Shou-Yeh Gong, et al.Leukemia|February 10, 2019
Prognostic restaging at the time of second-line therapy in patients with AL amyloidosisYi L Hwa, Morie A Gertz, Shaji K Kumar, et al.Blood Cancer Journal|May 8, 2020
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?M Hasib Sidiqi, Mohammed Aljama, Shaji K Kumar, et al.Brain Communications|March 20, 2024
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's diseaseKarin L Meeker, Patrick H Luckett, Nicolas R Barthélemy, et al.World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 18, 2021
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrumRobert F Krueger, Kelsey A Hobbs, Christopher C Conway, et al.American Journal of Hematology|January 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantationNadine H Abdallah, Thomas Habermann, Francis K Buadi, et al.Bone Marrow Transplantation|December 23, 2017
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosisSurbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.Blood Advances|November 23, 2018
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myelomaMohammed A Aljama, M Hasib Sidiqi, Arjun Lakshman, et al.American Journal of Hematology|April 5, 2019
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapyMarcella A Tschautscher, Dragan Jevremovic, Vincent Rajkumar, et al.Leukemia|June 29, 2017
Natural history of t(11;14) multiple myelomaA Lakshman, M Alhaj Moustafa, S V Rajkumar, et al.Pageof 46